E-mail a Wiley Online Library Link

Mark C. Genovese, Arthur Kavanaugh, Michael E. Weinblatt, Charles Peterfy, Julie DiCarlo, Michael L. White, Maryann O'Brien, Elliott B. Grossbard and Daniel B. Magilavy An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: A three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents Arthritis & Rheumatism 63

Version of Record online: 28 JAN 2011 | DOI: 10.1002/art.30114

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field